e-learning
resources
Munich 2006
Wednesday 06.09.2006
COPD: a systemic disease affecting the muscles
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of COPD on muscle structure and function
F. Maltais (Ste-Foy, Canada)
Source:
Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Session:
COPD: a systemic disease affecting the muscles
Session type:
Symposium
Number:
4784
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Maltais (Ste-Foy, Canada). The effect of COPD on muscle structure and function. Annual Congress 2006 - COPD: a systemic disease affecting the muscles
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Distribution of leg muscle weakness in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008
The disease spiral; what is it and does it exist?
Source: Annual Congress 2005 - Contemporary physiological approaches to reversing the disease spiral in advanced COPD
Year: 2005
Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006
The prevalence of quadriceps weakness in COPD and the relationship with disease severity
Source: Eur Respir J 2010; 36: 81-88
Year: 2010
Systemic inflammation in chronic respiratory disease
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=46
Year: 2003
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
How to augment rehabilitation in very severe COPD
Source: Annual Congress 2005 - Contemporary physiological approaches to reversing the disease spiral in advanced COPD
Year: 2005
Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 280-285
Year: 2003
Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011
Carnitine deficiency in chronic obstructive pulmonary disease patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Risk of severe exacerbations in COPD patients associates with mass of intercostal and abdominal muscles: a CT scan study
Source: Annual Congress 2006 - Respiratory muscles
Year: 2006
Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 137-142
Year: 2004
Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α
1
-Antitrypsin deficiency: molecular and clinical news
Year: 2007
Change in muscle mass in training patients with chronical obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept